Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biovest International Inc.

Division of Accentia Biopharmaceuticals Inc.
www.biovest.com

Latest From Implant Innovations Inc.

Colbar R&D Ltd.

Israeli-based Colbar R&D ltd has a technology that offers a more durable scaffold for tissue engineering. The technology allows for the first time the precise programming of the collagen matrix that is used in tissue repair. The three year old company has a dental product for tooth implantation on the market in the US and a second product for correcting contour deficiencies in clinical trials in Europe.
Medical Device Business Strategies

Orthovita: The Most Natural Thing

The spinal orthopedics business, long focused on traditional fixation tools such as screws, dowels, cements, and more recently, interbody fusion cages, has been undergoing a slow evolution that also incorporates a biological approach to bone healing. Orthovita believes its glass/resin-based bioactive materials mimic the biology of bone healing better than previous synthetics, and that these materials can more easily incorporate biologic agents for an added bone-healing boost. Now the company faces the challenge of generating the data that will differentiate it from a host of competitors making similar claims and enable it to penetrate a market inherently slow to adopt new technology.
Medical Device Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cellex Biosciences Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Accentia Biopharmaceuticals Inc.
  • Senior Management
  • Carlos F Santos, CEO
    James McNulty, CFO
  • Contact Info
  • Biovest International Inc.
    Phone: (508) 793-0001
    377 Plantation St.
    Biotech Bldg. 4
    Worcester, MA 01605
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register